Kenneth H Fife
Overview
Explore the profile of Kenneth H Fife including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
2656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Der Pol B, Torres-Chavolla E, Kodsi S, Cooper C, Davis T, Fife K, et al.
Sex Transm Dis
. 2021 Jan;
48(2):134-140.
PMID: 33448727
Background: Diagnostic options to combat the increasing rates of sexually transmitted infections recorded throughout the world increasingly include multiplex assays. Here we describe the estimated sensitivity and specificity of a...
2.
Katzenellenbogen R, Fife K
JAMA Netw Open
. 2019 Oct;
2(10):e1914038.
PMID: 31651962
No abstract available.
3.
4.
Fan H, Fife K, Cox D, Cox A, Zimet G
AIDS Care
. 2018 Feb;
30(8):1062-1069.
PMID: 29466877
Findings: therefore, may be subject to recall bias and to difficulties determining the direction of associations. In this prospective study, we administered surveys to women in community clinics to identify...
5.
Gaydos C, Beqaj S, Schwebke J, Lebed J, Smith B, Davis T, et al.
Obstet Gynecol
. 2017 Jun;
130(1):181-189.
PMID: 28594779
Objective: Vaginitis may be diagnosed as bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, or coinfection. A new molecular test assays the vaginal microbiome and organisms that cause three common infections. The objective...
6.
7.
Fife K, Mugwanya K, Thomas K, Baeten J, Celum C, Bukusi E, et al.
J Infect Dis
. 2015 Dec;
213(10):1573-8.
PMID: 26704611
Background: Immune reconstitution inflammatory syndrome (IRIS) in human immunodeficiency virus (HIV)-infected persons beginning antiretroviral therapy (ART) has been incompletely characterized for herpes simplex virus type 2 (HSV-2). Methods: We evaluated...
8.
Magaret A, Mujugira A, Hughes J, Lingappa J, Bukusi E, deBruyn G, et al.
Clin Infect Dis
. 2015 Nov;
62(4):456-61.
PMID: 26578538
Background: The efficacy of condoms for protection against transmission of herpes simplex virus type 2 (HSV-2) has been examined in a variety of populations with different effect measures. Often the...
9.
Ndase P, Celum C, Kidoguchi L, Ronald A, Fife K, Bukusi E, et al.
PLoS One
. 2015 Apr;
10(4):e0123005.
PMID: 25885664
Background: Rapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid...
10.
Kasting M, Cox A, Cox D, Fife K, Katz B, Zimet G
BMC Med
. 2014 Nov;
12:204.
PMID: 25374047
Background: Nearly 1 in 5 people living with HIV in the United States are unaware they are infected. Therefore, it is important to develop and evaluate health communication messages that...